| ²é¿´: 508 | »Ø¸´: 2 | ||
ؼÎçºóÑô¹â½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
challengeºÍadministrationµÄÊÍÒå ÒÑÓÐ2È˲ÎÓë
|
|
e.g. To assess the effects of (Fig. 2) on eosinophilia in OVA-challenged mice, cells recruited to the BAL-fluid were counted 48 h after the last challenge. e.g. Oral administration of 25 or 50 mg/kg 1 h before OVA challenge significantly suppressed the number of eosinophils and total inflammatory cells in a dose-dependent manner ¿´ÎÄÏ×¾³£¿´µ½ÕâÁ½¸öµ¥´Ê£¬ÇóÎÊÔÚÁ½¸öÀý¾äÖÐ×÷ºÎÒâ˼£¿Ð»Ð»£¡ÁíÎÊBALÊÇɶ¶«Î÷¡£¡£ |
» ²ÂÄãϲ»¶
272·Ö²ÄÁÏ×ÓÇóµ÷¼Á
ÒѾÓÐ36È˻ظ´
275Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
µ÷¼ÁÇóÊÕÁô
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ19È˻ظ´
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ33È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸¹þ¹¤´ó 085600 277 12²Ä¿Æ»ùÇóµ÷¼Á
ÒѾÓÐ17È˻ظ´
»¹Óл¯¹¤¶þÂÖµ÷¼ÁµÄѧУÂð
ÒѾÓÐ47È˻ظ´

ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ؼÎçºóÑô¹â: ½ð±Ò+5, ¸Ðл£¡ 2014-09-10 12:20:16
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ؼÎçºóÑô¹â: ½ð±Ò+5, ¸Ðл£¡ 2014-09-10 12:20:16
|
challengeÔÚÕâÀïÊǼ¤·¢¡¢´Ì¼¤µÄÒâ˼£¬¸üÖ±½ÓµÄ¾ÍÊÇÓÃxx´¦Àí£¨¶¯Î¡£µÚÒ»¾äÖеÄBAL£fluidÓ¦¸ÃÊÇÖ§Æø¹Ü·ÎÅݹàÏ´Òº£¬²»ÖªÊÇ·ñ·ûºÏÄãµÄÉÏÏÂÎÄ¡£ Oral administrationÊǿڷþ¸øÒ©£¨ÓÃÒ©£©µÄÒâ˼¡£ÓëÆ¤Ï¡¢¸¹Ç»¸øÒ©Ïà¶ÔÓ¦... |
2Â¥2014-09-09 22:47:22
¶¡Æä³¿
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 281.4
- Ìû×Ó: 43
- ÔÚÏß: 140.3Сʱ
- ³æºÅ: 2801017
- ×¢²á: 2013-11-14
- רҵ: Ó¦Óø߷Ö×Ó»¯Ñ§ÓëÎïÀí
3Â¥2014-09-10 11:23:48













»Ø¸´´ËÂ¥